Research is ongoing to explore the potential of reversing MLH1 promoter methylation. Epigenetic therapies, such as DNA demethylating agents, are being investigated for their ability to reactivate silenced MLH1 genes. However, the clinical application of these therapies is still in the experimental stages.
